Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis

JACC: Heart Failure

Volumn 4, Issue 10, 2016, Pages 772-779

  Vakil, Kairav ^a,b   Kazmirczak, Felipe ^b   Sathnur, Neeraj ^b   Adabag, Selcuk ^a,b   Cantillon, Daniel J ^c   Kiehl, Erich L ^c   Koene, Ryan ^b   Cogswell, Rebecca ^b   Anand, Inderjit ^d   Roukoz, Henri ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

implantable cardioverter defibrillator; left ventricular assist device; meta analysis; mortality; systematic review

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALL CAUSE MORTALITY; ARTICLE; CLINICAL EFFECTIVENESS; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DEFIBRILLATION; DEVICE INFECTION; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR ASSIST DEVICE; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT INDICATION; CAUSE OF DEATH; COMPLICATION; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART FAILURE; HEART STROKE VOLUME;

ARRHYTHMIAS, CARDIAC; CAUSE OF DEATH; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MORTALITY; STROKE VOLUME;

EID: 84991628251     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2016.05.003     Document Type: Article

References (28)

1. 1 Jorde, U.P., Kushwaha, S.S., Tatooles, A.J., et al. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 63 (2014), 1751–1757.
2. 2 Rose, E.A., Gelijns, A.C., Moskowitz, A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 (2001), 1435–1443.
3. 3 Slaughter, M.S., Rogers, J.G., Milano, C.A., et al. Advanced heart failure treated with continuous–flow left ventricular assist device. N Engl J Med 361 (2009), 2241–2251.
4. 4 Kirklin, J.K., Naftel, D.C., Kormos, R.L., et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 32 (2013), 141–156.
5. 5 McIlvennan, C.K., Magid, K.H., Ambardekar, A.V., Thompson, J.S., Matlock, D.D., Allen, L.A., Clinical outcomes after continuous-flow left ventricular assist device: a systematic review. Circ Heart Fail 7 (2014), 1003–1013.
6. 6 Mancini, D., Colombo, P.C., Left ventricular assist devices: a rapidly evolving alternative to transplant. J Am Coll Cardiol 65 (2015), 2542–2555.
7. 7 Bedi, M., Kormos, R., Winowich, S., McNamara, D.M., Mathier, M.A., Murali, S., Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 99 (2007), 1151–1153.
8. 8 Fasseas, P., Kutalek, S.P., Kantharia, B.K., Prolonged sustained ventricular fibrillation without loss of consciousness in patients supported by a left ventricular assist device. Cardiology 97 (2002), 210–213.
9. 9 Oz, M.C., Rose, E.A., Slater, J., Kuiper, J.J., Catanese, K.A., Levin, H.R., Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol 24 (1994), 1688–1691.
10. 10 Salzberg, S.P., Lachat, M.L., Zund, G., Turina, M.I., Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation. Eur J Cardiothorac Surg 26 (2004), 444–446.
11. 11 Sims, D.B., Rosner, G., Uriel, N., Gonzalez-Costello, J., Ehlert, F.A., Jorde, U.P., Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device. Pacing Clin Electrophysiol 35 (2012), e144–e148.
12. 12 Andersen, M., Videbaek, R., Boesgaard, S., Sander, K., Hansen, P.B., Gustafsson, F., Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant 28 (2009), 733–735.
13. 13 Cantillon, D.J., Tarakji, K.G., Kumbhani, D.J., Smedira, N.G., Starling, R.C., Wilkoff, B.L., Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm 7 (2010), 466–471.
14. 14 Enriquez, A.D., Calenda, B., Miller, M.A., Anyanwu, A.C., Pinney, S.P., The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol 6 (2013), 668–674.
15. 15 Garan, A.R., Yuzefpolskaya, M., Colombo, P.C., et al. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?. J Am Coll Cardiol 61 (2013), 2542–2550.
16. 16 Lee, W., Tay, A., Subbiah, R.N., et al. Impact of implantable cardioverter defibrillators on survival of patients with centrifugal left ventricular assist devices. Pacing Clin Electrophysiol 38 (2015), 925–933.
17. 17 Refaat, M.M., Tanaka, T., Kormos, R.L., et al. Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients. J Cardiac Fail 18 (2012), 140–145.
18. 18 Vakil, K., Roukoz, H., Sarraf, M., et al. Safety and efficacy of the MitraClip system for severe mitral regurgitation: a systematic review. Catheter Cardiovasc Interv 84 (2014), 129–136.
19. 19 Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS, 6, 2009, e1000097.
20. 20 Adabag, S., Roukoz, H., Anand, I.S., Moss, A.J., Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis. J Am Coll Cardiol 58 (2011), 935–941.
21. 21 Downs, S.H., Black, N., The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of epidemiology and community health 52 (1998), 377–384.
22. 22 Galvagno, S.M. Jr., Thomas, S., Stephens, C., et al. Helicopter emergency medical services for adults with major trauma. Cochrane Database Syst Rev, 3, 2013, CD009228.
23. 23 DerSimonian, R., Laird, N., Meta–analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
24. 24 Feldman, D., Pamboukian, S.V., Teuteberg, J.J., et al. The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 32 (2013), 157–187.
25. 25 Nakahara, S., Chien, C., Gelow, J., et al. Ventricular arrhythmias after left ventricular assist device. Circ Arrhythm Electrophysiol 6 (2013), 648–654.
26. 26 Miller, L.W., Pagani, F.D., Russell, S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357 (2007), 885–896.
27. 27 Ziv, O., Dizon, J., Thosani, A., Naka, Y., Magnano, A.R., Garan, H., Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol 45 (2005), 1428–1434.
28. 28 Brenyo, A., Rao, M., Koneru, S., et al. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol 23 (2012), 515–520.